nach oben

Erschienen in:

01.04.2012 | Original Article

The prevalences of some rheumatic diseases in western Turkey: Havsa study

verfasst von: Necati Çakır, Ömer Nuri Pamuk, Emine Derviş, Neşe İmeryüz, Haşim Uslu, Ömer Benian, Edip Elelçi, Genco Erdem, Fatma Oğuz Sarvan, Mustafa Şenocak

Erschienen in: Rheumatology International | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

To study the prevalence major rheumatic diseases in western Turkey. This survey was conducted in Havsa which have a total population of 18,771. Physicians and interns visited every household, interviewed face to face a questionnaire about the symptoms of rheumatic disorders. The individuals replied positively to any question were examined at the nearest health center. Those have no objective findings related to any rheumatic diseases were excluded. People could not be clinically diagnosed were asked to come to the hospital for further evaluation. A total 17,835 of 18,771 residents participated. We estimated the prevalence of Behçet’s Disease (BD) as 0.019%; ankylosing spondylitis: 0.120%; rheumatoid arthritis: 0.321%; knee osteoarthritis (OA): 5.351%; hand OA: 1.110%; hand and knee OA: 1.958%; total OA: 8.420%; primary Raynaud’s: 1.192%; psoriasis: 0.424 %; psoriatic arthritis: 0.050%; rheumatic fever: 0.318%; rheumatic heart disease: 0.200%; inflammatory bowel disease: 0.023%; lupus: 0.059%; gout: 0.018%; systemic sclerosis: 0.022%; juvenile rheumatoid arthritis: 0.032%; temporal arteritis: 0.020%, and familial Mediterranean fever (FMF) as 0.006%. Figures were adjusted for age-sex of the general Turkish population. The prevalence’s of BD and FMF are considerably lower in Havsa as compared to other regions in Turkey.

Silman AJ, Hochberg MC (2001) Epidemilogy of the rheumatic disases, 2nd edn. Oxford University Press, Oxford

Demirhindi O, Yazıcı H, Binyıldız P (1981) Silivri Fener Köyü ve Yöresinde Behçet Hastalığı sıklığı ve bu hastalığın toplum içinde taranmasında kullanılabilecek bir yöntem. Cerrahpaşa Tıp–Fak Der 12:509–514

Yurdakul S, Günaydın I, Tüzün Y, Tankurt N, Pazarli H, Ozyazgan Y et al (1988) The prevalence of Behçet’s syndrome in a rural area Northern Turkey. J Rheumatol 15:115–117

Idil A, Gurler A, Boyvat A, Caliskan D, Ozdemir O, Isik A et al (2002) The prevalence of Behçet’s disease above the age of ten years. The results of a pilot study conducted at the Park Primary Health Care Center in Ankara, Turkey. Ophthalmic Epidemiol 9:325–331PubMedCrossRef

Azizlerli G, Kose AK, Sarıca R, Gul A, Tutkun IT, Kulaç M et al (2003) Prevalence of Behçet’s disease in İstanbul, Turkey. Int J Dermatol 42:803–806PubMedCrossRef

Akar S, Birlik M, Gurler O, Sari I, Onen F, Manisali M et al (2004) The prevalence of rhematoid arthritis in an urban population of İzmir–Turkey. Clin Exp Rheumatol 22:416–420PubMed

Kacar C, Gilgil E, Tuncer T, Bütün B, Urhan S, Arikan V et al (2005) Prevalence of rheumatoid arthritis in Antalya, Turkey. Clin Rheumatol 24:212–214PubMedCrossRef

Ozen S, Karaaslan Y, Ozdemir O, Saatci U, Bakkaloglu A, Koroglu E et al (1998) Prevalence of chronic arthritis and familial Mediterranean fever in Turkey: a field survey. J Rheumatol 25:2445–2449PubMed

Cobankara V, Fidan G, Türk T, Zencir M, Colakoglu M, Ozen S et al (2004) The prevalence of familial Mediterranean fever in the Turkish province of Denizli: a field study with a zero patient design. Clin Exp Rheumatol 22(suppl, 34):S27–S30PubMed

10.

Onen F, Sumer H, Turkay S, Akyurek O, Tunca M, Ozdogan H et al (2004) Increased frequency of familial Mediterranean fever in Central Anatolia Turkey. Clin Exp Rheumatol 22(Suppl.34):31–33

11.

Dinc A, Pay S, Turan M, Simsek I (2000) Prevalence of familial Mediterranean fever in young Turkish men. Clin Exp Rheumatol 18(Supl):292

12.

Onen F, Akar S, Birlik M, Sari I, Khan MA, Gurler O et al (2008) Prevalence of ankylosing spondyloarthritis and related spondyloarthritides in an urban area of Izmir, Turkey. J Rheumatol 35:305–309PubMed

13.

Cakir N, Dervis E, Benian O, Pamuk ON, Sonmezates N, Rahimoglu R et al (2004) Prevalence of Behçet’s dieases in rural western Turkey: a preliminary report. Clin Exp Rheumatol 22(Suppl. 34):S53–S55PubMed

14.

Gustincich S, Manfiolett G, Del Sal G, Carninci PA (1991) Fast method for high quality genomic DNA extraction from whole human blood. Bio Tech 11:298–302

15.

Buyse R, Decorte M, Baens Z (1993) Rapid DNA typing of class II antigens using the PCR and reverse dot blot hybridization. Tissue Antigens 41:1–14PubMedCrossRef

16.

International study Group for Behçet’s Dieseas (1990) Criteria for diagnosis of Behçet’s diease. Lancet 335:1078–1080

17.

MacGregor AJ, Bamber S, Silman AJ (1994) A comparison of the performance of different methods of disease classification for rheumatoid arthritis. Results of analysis from a nationwide twin study. J Rheumatol 21:1420–1426PubMed

18.

Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al (1982) The 1982 revise criteria for the classification of systemic lupus erythematosus (SLE). Aritritis Rheum 25:1271–1277CrossRef

19.

Brewer EJ Jr, Bass J, Baum J, Cassidy JT, Fink C, Jacobs J et al (1977) JRA Criteria Subcommite of the diagnosis and therapeutic Critera Committee of the American Rheumatism Association: current proposed revision of JRA criteria. Arthritis Rheum 20:195–199PubMed

20.

Kellgren JH, Jeffrey M, Ball J (1963) The epidemiolgy of chronic rheumatism, vol 1. Blackwell, Oxford, pp 32–37

21.

Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T et al (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthrits Rheum 40:1879–1885CrossRef

22.

Subcommitte for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581–90

23.

Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K et al (1986) Development of critreria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29:1039–1049PubMedCrossRef

24.

Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K et al (1990) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthritis Rheum 33:1601–1610PubMedCrossRef

25.

Brennan P, Silman A, Black C, Bernstein R, Coppock J, Maddison P et al (1993) Validity and reliability of three methods used in the diagnosis of Raynaud’s phenomenon. The UK Scleroderma study group. Br J Rheumatol 32:357–361PubMedCrossRef

26.

Dajani AS (2001) Rheumatic fever. Guidelines for the diagnosis of initial attacts of rheumatic fever (Jones Criteria, updated 1992). Heart disease: a textbook of cardiovascular disease. Eugene Branwald, Douglas P Zipes, Peter Libby, pp 2192–2197

27.

Nomenclature and Criteria for Diagnosis of the Heart and Great Vessels. The Criteria Committe of the New York Heart Association. 1979; 8th edn, p 260

28.

Baker H (2001) Criteria for borderline psoriasis. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, p 86

29.

Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A et al (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 34:1218–1227PubMedCrossRef

30.

Van der Linden S, Valkenburg HA, Cats A (1994) Evulation of diagnosis criteria for ankylosing spondylitis. A proposal for modification of the New York Criteria. Arthritis Rheum 27:361–368CrossRef

31.

Tobi H, van den Berg PB, den Berg LT (2005) Small proportions: what to report for confidence intervals? Pharmacoepidemiol Drug Saf 14:239–247PubMedCrossRef

32.

Cakir N, Yazici H, Chamberlain MA, Barnes CG, Yurdakul S, Atasoy S et al (1991) Response to intradermal injection of monosodium urate crystals in Behçet’s syndrome. Ann Rheum Dis 50:634–636PubMedCrossRef

33.

Carmona L, Villaverde V, Hernández-García C, Ballina J, Gabriel R, Laffon A, EPISER Study Group (2002) The prevalence of rheumatoid arthritis in the general population of Spain. Reumatology (Oxford) 41:88–95CrossRef

34.

Guillemin F, Saraux A, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E et al (2005) Prevalence of rheumatoid arthritis in France: 2001. Ann Rheum Dis 64:1427–1430PubMedCrossRef

35.

Drosos AA, Alamanos I, Voulgari PV, Psychos DN, Katsaraki A, Papadopoulos I et al (1997) Epidemiology of adult rheumatoid arthritis in northwest Greece 1987–1995. J Rheuamtol 24:2129–2133

36.

Stojanovic R, Vlajinac H, Palic-Obradovic D, Janosević S, Adanja B (1998) Prevalence of rheumatoid arthritis in Belgrade, Yugoslavia. Br J Reumatol 37:729–732CrossRef

37.

Andrianakos A, Trontzas P, Christoyannis F, Kaskani E, Nikolia Z, Tavaniotou E et al (2006) Prevalence and management of rheumatoid arthritis in the general population of Greece-the ESORDIG study. Rheumatology (Oxford) 45:1549–1554CrossRef

38.

Hanova P, Pavelka K, Dostal C, Holcatova I, Pikhart H, Hanova P (2006) Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey 2002–2003. Clin Exp Rheumatol 24:499–507PubMed

39.

Steven MM (1992) Prevalence of chronic arthritis in four geographical areas of the Scottish Highlands. Ann Rheum Dis 51:186–194PubMedCrossRef

40.

Salaffi F, De Angelis R, Grassi W, Salaffi F, De Angelis R, Grassi W (2005) MArche Pain Prevalence; INvestigation Group (MAPPING) study. Prevalence of musculoskeletal conditions in an Italian population sample:results of a regional community-based study.1. The MAPPING study. Clin Exp Rheumatol 23:819–828PubMed

41.

Solomon L, Robin G, Valkenburg HA (1975) Rheumatoid arthritis in an urban South African Negro population. Ann Rheum Dis 34:128–135PubMedCrossRef

42.

Meyers OL, Daynes G, Beighton P (1977) Rheumatoid arthritis in a tribal Xhosa population in the Transkei, Southern Africa. Ann Rheum Dis 36:62–65PubMedCrossRef

43.

Beighton P, Solomon L, Valkenburg HA (1975) Rheumatoid arthritis in a rural South African Negro population. Ann Rheum Dis 34:136–141PubMedCrossRef

44.

Moolenburgh JD, Valkenburg HA, Fourie PB (1986) A population study on rheumatoid arthritis in Lesotho, southern Africa. Ann Rheum Dis 45:691–695PubMedCrossRef

45.

Brighton SW, de la Harpe AL, van Staden DJ, Badenhorst JH, Myers OL (1988) The prevalence of rheumatoid arthritis in a rural African population. J Rheumatol 15:405–408PubMed

46.

Dai SM, Han XH, Zhao DB, Shi YQ, Liu Y, Meng JM (2003) Prevalence of rheumatic symptoms, rheumatoid arthritis, ankylosing spondylitis, and gout in Shanghai, China; a COPCORD Study. J Rheumatol 30:2245–2251PubMed

47.

Wigley RD, Zhang NZ, Zeng QY, Shi CS, Hu DW, Couchman K et al (1994) Rheumatic Diseases In China: ILAR-China Study comparing the prevalance of rheuamtic symptoms in Northern and Southern rural populations. J Rheumatol 21:1484–1490PubMed

48.

Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH (1994) Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol 21:302–306PubMed

49.

Malaviya AN, Kapaoor SK, Singh RR, Kumar A, Pande I (1993) Prevalence of rheumatoid arthritis in the adult Indian population. Rheumatol Int 13:131–134PubMedCrossRef

50.

Minh Hoa TT, Darmawan J, Chen SL, Van Hung N, Thi Nhi C, Ngoc An T (2003) Prevalence of the rheumatic diseases in urban Vietnam: a WHO-ILAR COPCORD study. J Rheumatol 30:2252–2256PubMed

51.

Darmawan J, Muirden KD, Valkenburg HA, Wigley RD (1993) The epidemiology of rheumatoid arthritis in Indonesia. Br J Rheumatol 32:537–540PubMedCrossRef

52.

Chopra A, Patil J, Billempelly V, Relwani J, Tandle HS (2001) WHO-ILAR COPCORD Study. WHO International League of Associations from Rheumatology Community Oriented Program from Control of Rheumatic Diseases. Prevalence of rheumatic diseases in a rural population in western India: a WHO-ILAR COPCORD Study. J Assoc Physicians India 49:240–246PubMed

53.

Dans LF, Tankeh-Torres S, Amanta CM, Penserge EG (1997) The prevalence of rheumatic diseases in a Filipino urban population: a WHO-ILAR COPCORD Study: World Health Organization. International Leaque of Associations for Rheumatololgy. Community Oriented Programmme for the Control of the Rheumatic Diseases. J Rheumatol 24:1814–1819PubMed

54.

Zeng QY, Chen R, Darmawan J, Xiao ZY, Chen SB, Wigley R et al (2008) Rheumatic diseases in China. Arhritis Res Ther 10(1):R17CrossRef

55.

Uddin MZ, Das BB, Rahman F, Chowdhury MA, Alam MN, Mahmud TA et al (2005) Prevalence of rheumatic diseases and associated outcomes in rural and urban communities in Bangladesh: a COPCORD study. J Rheumatol 32:348–353PubMed

56.

Pountain G (1991) The prevalence of rheumatoid arthritis in the Sultanate of Oman. Br J Rheumatol 30:24–28PubMedCrossRef

57.

Al-Dalan A, Al Ballaa S, Bahabri S, Biyari T, Al Sukait M, Mousa M et al (1998) The prevalence of rheumatoid arthritis in the Qassim region of Saudi Arabia. Ann Saudi Med 18:396–397

58.

Lawrence RC, Helmic CG, Arnett FC, Deyo RA, Felson DT, Giannini EH et al (1998) Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 41:778–799PubMedCrossRef

59.

Gabriel SE, Crowson CS, O’Fallon WM (1999) The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955–1985. Arth Rheum 42:415–420CrossRef

60.

Boyer GS, Lanier AP, Templein DW, Bulkow L (1990) Spondylopathy and rheumatoid arthritis Alaskan Yupik Eskimos. J Rheumatol 17:489–496PubMed

61.

Boyer GS, Templin DW, Lanier AP (1991) Diseases in Alaskan Indians of the southest coast. High prevalence of rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 18:1477–1484PubMed

62.

Gare BA, Fasth A (1992) Epidemiology of juvenile chronic arthritis in southwestern Sweden: a 5-year prospective population study. Pediatrics 90:950–958PubMed

63.

Danner S, Sordet C, Terzic J, Donato L, Velten M, Fischbach M et al (2006) Epidemiology of juvenile idiopathic arthritis in Alsace, France. J Rheumatol 33:1377–1381PubMed

64.

Manners PJ, Bower C (2002) Worldwide prevalence of juvenil arthritis—why does it vary so much? J Rheumatol 29:1520–1530PubMed

65.

Mauldin J, Cameron HD, Jeanotte D, Solomon G, Jarvis JN (2004) Chronic arthritis in children and adolescents in two Indian health service user populations. BMC Musculoskelet Disord 27:5–30

66.

Hochberg MC, Linet MS, Sills EM (1983) The prevalence and incidence of juvenil rheumatoid arthritis in an urban Black population. Am J Public Health 73:1202–1203PubMedCrossRef

67.

van Saase JL, van Romunde LK, Cats A, Vandenbroucke JP, Valkenburg HA (1989) Epidemiology of osteoarthritis: Zoetermer survey. Comparison of radiological osteoarthritis in a Dutch popultion with that in 10 other populations. Ann Rheum Dis 48:271–280PubMedCrossRef

68.

Andrianakos AA, Kontelis LK, Kramitsos DG, Aslanidis SI, Georgountzos AI, Kaziolas GO et al (2006) Prevalence of symptomatic knee, hand, and hip osteoarthritis in Greece.The ESORDIG Study. J Rheumatol 33:2507–2514PubMed

69.

Sun Y, Stürmer T, Günter KP, Brenner H (1997) Incidence and prevalence of cox-and gonarthrosis in the general population. Z Orthop Ihre Grenzgeb 135:184–192 (abstract)PubMedCrossRef

70.

Jordan JM, Helmick CG, Renner JB, Luta G, Dragomir AD, Woodard J et al (2007) Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: The Jhonson County. Osteoarthritis Project. J Rheumatol 34:172–180PubMed

71.

Kaçar C, Gilgil E, Urhan S, Arikan V, Dündar U, Oksüz MC et al (2005) The prevalence of symptomatic knne and distal interphalangeal joint osteoarthritis in the urban population of Antalya.Turkey. Rheumatol Int 25:201–204PubMedCrossRef

72.

Saraux A, Guillemin F, Guggenbuhl P, Roux CH, Fardellone P, Le Bihan E et al (2005) Prevalence of spondyloarthropathies in France: 2001. Ann Rheum Dis 64:1431–1435PubMedCrossRef

73.

Alamanos Y, Papadopoulos NG, Voulgari PV, Karakatsanis A, Siozos C, Drosos AA (2004) Epidemiology of ankylosing spondylitis in northwest Greece, 1983–2002. Rheumatology 43:615–618PubMedCrossRef

74.

Trontzas P, Andrianakos A, Miyakis S, Pantelidou K, Vafiadou E, Garantziotou V (2005) The ESORDIG study group. Seronegative spondyloarthopathies in Greece: a population-based study of prevalence, clincal pattern, and management. The ESORDIG study group. Clin Rheumatol 24:583–589PubMedCrossRef

75.

Silman AJ (2001) Ankylosing spondylitis and spondyloarthropathies. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, pp 100–101

76.

Ng SC, Liao Z, Yu DT, Chan ES, Zhao L, Gu J (2007) Epidemiology of spondyloarthritis in the People’s Republic of China: review of the the literatutre and commentary. Semin Arthritis Rheum 37:39–47PubMedCrossRef

77.

Saro Gismera C, Riestra Menéndez S, Milla Crespo A, Sánchez Fernandez R, Lacort Fernandez M, Argüelles Fernandez G et al (2003) Incidence and prevalence of inflammatory bowel disease. Asturian study in 5 areas (EIICEA), Spain. Ann Med Interna 20:3–9

78.

Rubin GP, Hungin AP, Kelly PJ, Ling J (2000) Inflammatory bowel disease: epidemiology and management in an English general practice population. Aliment Pharmacol Ther 14:1553–1559PubMedCrossRef

79.

Gearry RB, Richardson A, Frampton CM, Collett JA, Burt MJ, Chapman BA et al (2006) High incidence of Crohn’s disease in Canterbury, New Zeland: results of an epidemiology study. Inflamm Bowel Dis 12:936–943PubMedCrossRef

80.

Abdul-Baki H, ElHajj I, El-Zahabi LM, Azar C, Aoun E, Zantout H et al (2004) Clinical epidemiology of inflamattory bowel disease in Lebanon. Inflamm Bowel Dis 13:475–480CrossRef

81.

Pinchbeck BR, Kirdeikis J, Thomson AB (1988) Inflammatory bowel disease in northern Alberta. An epidemiologic study. J Clin Gastroenterol 10:505–515PubMedCrossRef

82.

Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M et al (2006) The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 101:1559–1568PubMedCrossRef

83.

Herrinton LJ, Liu L, Lafata JE, Allison JE, Andrade SE, Korner EJ et al (2007) Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis 4:451–461CrossRef

84.

Nevitt GJ, Hutchinson PE (1996) Psoriasis in the community: prevalence, severity and patient’s beliefs and attitudes towards the disease. Br J Dermatol 135:533–537PubMedCrossRef

85.

Ferrándiz C, Bordas X, García-Patos V, Puig S, Pujol R, Smandía A et al (2001) Prevalence of psoriasis in Spain (Epiderma Project: phase 1). J Eur Acad Dermatol Venerol 15:20–23CrossRef

86.

Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ (2005) Prevalence and treatment of psoriasis in the United Kingdom. A population-based study. Arch Dermatol 141:1537–1541PubMedCrossRef

87.

Braathen LR, Botten G, Bjerkedal T (1989) Psoriatics in Norway. A questionnaire study on health status, contact with paramedical professions, and alcohol and tobacco consumption. Acta Derm Venerol Suppl (Stockh) 142:9–12

88.

Falk ES, Vandbakk O (1993) Prevalence of Psoriasis in a Norwegian Lapp population. Acta Derm Venerol Suppl (Stockh) 182:6–9

89.

Silman AJ (2001) Psoriatic arthropathy. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, pp 85–99

90.

Taylor WJ (2002) Epidemiology of psoriatic arthritis. Curr Opin Rheumatol 14:98–103PubMedCrossRef

91.

Madland TM, Apalset EM, Johannesen AE, Rossebö B, Brun JG (2005) Prevalence, disesae manifestations, and treatment of psoriatic arthritis in Western Norway. J Rheumatol 32:1918–1922PubMed

92.

Alamanos Y, Papadopoulos NK, Voulgari PV, Siozos C, Psychos DN, Tympanidou M et al (2003) Epidemiology of psoriatic arthritis in Northwest Greece, 1982–2001. J Rheumatol 30:2641–2644PubMed

93.

Shbeeb M, Uramoto KM, Gibson LE, O’Fallon WM, Gabriel SE (2000) The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991. J Rheumatol 27:1247–1250PubMed

94.

Nakae K, Masaki F, Hashimoto T (1993) Recent epdemiological features of Behçet’s disease in Japan. In: Godea P, Wechsler B (eds) Behçet’s disease. Proceedings of the 6th ınternational conference on Behçet’s disease. Elsevier, Amsterdam, pp 145–151

95.

Hochberg MC (2001) Gout. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, pp 230–246

96.

Darmawan J, Valkenburg HA, Muirden KD, Wigley RD (1992) The epidemiology of gout and hyperuricemia in a rural population of Java. J Rheumatol 19:1595–1599PubMed

97.

Nossent HC (2001) Systemic lupus erythematosus in the Arctic region of Norway. J Rheumatol 28:539–546PubMed

98.

Govoni M, Castellino G, Bosi S, Napoli N, Trotta F (2006) Incidence and prevalence of systemic lupus erythematosus in a district of north Italy. Lupus 15:110–113PubMedCrossRef

99.

Johnson AE, Gordon C, Palmer RG, Bacon PA (1995) The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth. Arthritis Rheum 38:551–558PubMedCrossRef

100.

Hopkinson ND, Doherty M, Powell RJ (1994) Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 53:675–680PubMedCrossRef

101.

Nightingale Al, Farmer RD, de Vries CS (2007) Systemic lupus erythematosus prevalence in the UK: methodological issues when using the General Practice Research Database to estimate frequency of chronic relapsing-remitting disease. Pharmacoepidemiol Drug Saf 16:144–151PubMedCrossRef

102.

Samanta A, Feehally J, Roy S, Nichol FE, Sheldon PJ, Walls J (1991) High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 50:490–492PubMedCrossRef

103.

Danchenko N, Saita JA, Anthony MS (2006) Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden. Lupus 15:308–318PubMedCrossRef

104.

Al-Arfaj AS, Al-Balla SR, Al-Dalaan AN, Al-Saleh SS, Bahabri SA, Mousa MM et al (2002) Prevalence of systemic erythematosus in central Saudi Arabia. Saudi Med J 23:87–89PubMed

105.

Naleway AL, Davis ME, Greenlee RT, Wilson DA, McCarty DJ (2005) Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus 14:862–866PubMedCrossRef

106.

Bernatsky S, Joseph L, Pineau CA (2007) A population-based assessment of systemic lupus erythematosus incidence and prevalence-results and implications of using administrative data for epidemiological studies. Rheumatology (Oxford) 46:1814–1818CrossRef

107.

Jimenez S, Cervera R, Font J, Ingelmo M (2003) The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol 25:3–12PubMedCrossRef

108.

Ward MM (2004) Prevalence of physician-diagnosed systemic lupus eryhematosus in the United Stades: results from the third national health and nutrition examination survey. J Womens Health (Larchmt) 13:713–718 (abstract)CrossRef

109.

Hochberg MC, Perlmutter DL, Medsger TA, Steen V, Weisman MH, White B et al (1995) Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA. Lupus 4:454–456PubMedCrossRef

110.

Silman AJ (2001) Scleroderma. In: Silman AJ, Hochberg MC (eds) Epidemiology of the rheumatic diseases, 2nd edn, pp 141–162

111.

Mayes MD (1997) Epidemiology of systemic sclerosis and related diseases. Curr Opin Rheumatol 9:557–561PubMedCrossRef

112.

Maricq HR, Weinrich MC, Keil JE, Smith EA, Harper FE, Nussbaum AI et al (1989) Prevalence of scleroderma spectrum disorders the general population of south Carolina. Arhritis Rheum 32:998–1006CrossRef

113.

Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ et al (2003) Prevalence, incidence, survival, and disease charecteristics of systemic sclerosis in a large US population. Arthritis Rheum 48:2246–2255PubMedCrossRef

114.

Voulgari PV, Alamanos Y, Papazisi D, Christou K, Papanikolaou C, Drosos AA (2000) Prevalence of Raynaud’s phenomenon in a healthy Greek population. Ann Rheum Dis 59:206–210PubMedCrossRef

115.

Román Ivorra JA, Gonzálvez Perales JL, Fernández Carballido C, Graña J, Torres MJ (2001) Prevalence of Raynaud’s phenomenon practice in the east of Spain. Clin Rheumatol 20:88–90PubMedCrossRef

116.

Palmer KT, Griffin MJ, Sydall H, Pannett B, Cooper C, Coggon D (2000) Prevalence of Raynaud’s phenomenon in Great Britain and its relation to hand transmitted vibration: a national postal survey. Occup Environ Med 57:448–452 (abstract)PubMedCrossRef

117.

De Angelis R, Salaffi F, Grassi W (2006) Raynaud’s phenomenon: prevalence in Italian population sample. Clin Rheumatol 25:506–510PubMedCrossRef

118.

Weinrich MC, Maricq HR, Keil JE, McGregor AR, Diat F (1990) Prevalence of Rayanud’s phenomenon in the adult population of South Carolina. J Clin Epidemiol 43:1343–1349PubMedCrossRef

119.

Gelber AC, Wigley FM, Stallings RY, Bone LR, Barker AV, Baylor I et al (1999) Symptoms of Raynaud’s phenomenon in an iner-city African-American community: prevalence and self reported cardiovascular comorbidity. J Clin Epidemiol 52:441–446PubMedCrossRef

120.

Onbasi K, Sahin I, Onbasi O, Ustün Y, Koca D (2005) Raynaud’s phenomenon a healthy Turkish population. Clin Rheumatol 24:365–369PubMedCrossRef

121.

Pirim I, Atasoy M, Ikbal M, Erdem T, Aliagaoglu C (2004) HLA class I and class II genotyping in patients with Behcet’s disease: a regional study of eastern part of Turkey. Tissue Antigens 64:293–297PubMedCrossRef

122.

Uyar FA, Dorak MT, Saruhan-Direskeneli G (2004) Human leuıkocyte antigen-A, -B and -C alleles and human leukocyte antigen haplotypes in Turkey: relationship to other populations. Tissue Antigens 64:180–187PubMedCrossRef

123.

Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S (1997) Epidemiological and clinical features of Behçet’s disease in Korea. Yonsei Med J 38:428–436PubMed

124.

Onen F, Akar S, Birlik M, Sari I, Khan MA, Gurler O et al (2008) Prevalence of ankylosing spondylitis and related spondyloarthritides in an urban area of Izmir, Turkey. J Rheumatol 35:305–309PubMed

Titel: The prevalences of some rheumatic diseases in western Turkey: Havsa study
verfasst von: Necati Çakır
Ömer Nuri Pamuk
Emine Derviş
Neşe İmeryüz
Haşim Uslu
Ömer Benian
Edip Elelçi
Genco Erdem
Fatma Oğuz Sarvan
Mustafa Şenocak
Publikationsdatum: 01.04.2012
Verlag: Springer-Verlag
Erschienen in: Rheumatology International / Ausgabe 4/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI: https://doi.org/10.1007/s00296-010-1699-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

The prevalences of some rheumatic diseases in western Turkey: Havsa study

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Drei Mythen bei der Antibiotikatherapie

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2012

Cross-cultural adaptation and validation of the knee and hip health-related quality of life (OAKHQoL) in a Moroccan Arabic-speaking population

Health-related quality of life and utility in patients receiving biological and non-biological treatments in rheumatoid arthritis

Greek NHS capacity constraints regarding intravenous treatment for rheumatoid arthritis patients

Development of sarcoidosis following etanercept treatment: a report of three cases

Extremely high serum ferritin levels as a main diagnostic tool of adult-onset Still’s disease

Moderate loading of the human osteoarthritic knee joint leads to lowering of intraarticular cartilage oligomeric matrix protein

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Drei Mythen bei der Antibiotikatherapie

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

Update Innere Medizin